Literature DB >> 2500131

The effect of tumor necrosis factor alpha and gamma-interferon on the resorption of human articular cartilage and on the production of prostaglandin E and of caseinase activity by human articular chondrocytes.

R A Bunning1, R G Russell.   

Abstract

In cultured human articular chondrocytes, addition of tumor necrosis factor alpha (TNF alpha) stimulated caseinase activity over the range of 10(-11) M to 10(-7) M and stimulated prostaglandin E (PGE) production over the range of 10(-10) M to 10(-7) M. Maximal stimulation was observed at 10(-8)M TNF alpha for both activities. Gamma-interferon (gamma-IFN) had a variable effect on PGE production and no significant effect on caseinase activity in articular chondrocyte cultures over a concentration range of 0.1-1,000 units/ml. Co-incubation of TNF alpha with gamma-IFN enhanced PGE production and decreased caseinase activity. Concentrations as low as 1 unit/ml of gamma-IFN had significant effects on TNF-stimulated production of PGE and on caseinase activity. Resorption of human articular cartilage was stimulated by TNF alpha (10(-7) M) and was inhibited by gamma-IFN (1,000 units/ml). It is possible that cartilage breakdown in vivo may be modulated by such interactions between cytokines.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2500131     DOI: 10.1002/anr.1780320618

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  9 in total

1.  The regional sensitivity of chondrocyte gene expression to coactive mechanical load and exogenous TNF-α stimuli.

Authors:  S L Bevill; K A Boyer; T P Andriacchi
Journal:  J Biomech Eng       Date:  2014-09       Impact factor: 2.097

2.  Inhibition of interleukin 1-induced matrix metalloproteinase 13 expression in human chondrocytes by interferon gamma.

Authors:  R Ahmad; H Y Qureshi; M El Mabrouk; J Sylvester; M Ahmad; M Zafarullah
Journal:  Ann Rheum Dis       Date:  2006-12-19       Impact factor: 19.103

3.  Co-operation between interleukin-1 and the fibrinolytic system in the degradation of collagen by articular chondrocytes.

Authors:  S C Cruwys; D E Davies; E R Pettipher
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

4.  Prostaglandin E2 and its cognate EP receptors control human adult articular cartilage homeostasis and are linked to the pathophysiology of osteoarthritis.

Authors:  Xin Li; Michael Ellman; Prasuna Muddasani; James H-C Wang; Gabriella Cs-Szabo; Andre J van Wijnen; Hee-Jeong Im
Journal:  Arthritis Rheum       Date:  2009-02

5.  Influence of interleukin-1 beta, tumour necrosis factor alpha and prostaglandin E2 on chondrogenesis and cartilage matrix breakdown in vitro.

Authors:  H Mohamed-Ali
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

6.  Synovial activation of chondrocytes: evidence for complex cytokine interactions.

Authors:  G Bandara; H I Georgescu; C W Lin; C H Evans
Journal:  Agents Actions       Date:  1991-09

7.  Prostaglandin E2 receptor type 2-selective agonist prevents the degeneration of articular cartilage in rabbit knees with traumatic instability.

Authors:  Hiroto Mitsui; Tomoki Aoyama; Moritoshi Furu; Kinya Ito; Yonghui Jin; Takayuki Maruyama; Toshiya Kanaji; Shinsei Fujimura; Hikaru Sugihara; Akio Nishiura; Takanobu Otsuka; Takashi Nakamura; Junya Toguchida
Journal:  Arthritis Res Ther       Date:  2011-09-14       Impact factor: 5.156

Review 8.  Cartilage tissue engineering: From proinflammatory and anti‑inflammatory cytokines to osteoarthritis treatments (Review).

Authors:  Shuyu Liu; Zhenhan Deng; Kang Chen; Shengsheng Jian; Feifei Zhou; Yuan Yang; Zicai Fu; Huanyu Xie; Jianyi Xiong; Weimin Zhu
Journal:  Mol Med Rep       Date:  2022-01-28       Impact factor: 2.952

9.  Prostaglandin PGE2 at very low concentrations suppresses collagen cleavage in cultured human osteoarthritic articular cartilage: this involves a decrease in expression of proinflammatory genes, collagenases and COL10A1, a gene linked to chondrocyte hypertrophy.

Authors:  Elena V Tchetina; John A Di Battista; David J Zukor; John Antoniou; A Robin Poole
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.